Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

BACKGROUND: Studies on PD-L1 expression in breast cancer have gained importance in recent years, especially in triple-negative breast cancer (TNBC). Our aim was to analyze the differential expression of PD-L1 to explore its correlation with response to neoadjuvant chemotherapy (NACT) and patient sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Oner, Gizem, Önder, Semen, Karatay, Hüseyin, Ak, Naziye, Tükenmez, Mustafa, Müslümanoğlu, Mahmut, İğci, Abdullah, Dincçağ, Ahmet, Özmen, Vahit, Aydiner, Adnan, Yavuz, Ekrem, Cabioğlu, Neslihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414710/
https://www.ncbi.nlm.nih.gov/pubmed/34474671
http://dx.doi.org/10.1186/s12957-021-02361-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414710/
https://www.ncbi.nlm.nih.gov/pubmed/34474671
http://dx.doi.org/10.1186/s12957-021-02361-9

Ejemplares similares